Published in Microb Drug Resist on February 19, 2011
A rapid low-cost real-time PCR for the detection of Klebsiella pneumonia carbapenemase genes. Ann Clin Microbiol Antimicrob (2012) 0.81
Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis (2004) 9.21
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis (2013) 3.56
Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin Gastroenterol Hepatol (2007) 2.37
Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother (2012) 2.17
Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis (2012) 2.05
Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities. Clin Infect Dis (2008) 1.97
Biofilm formation by enterococci. J Med Microbiol (2007) 1.89
Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis (2003) 1.72
In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2004) 1.72
A review of an emerging enteric pathogen: enteroaggregative Escherichia coli. J Med Microbiol (2006) 1.54
Lysins: the arrival of pathogen-directed anti-infectives. J Med Microbiol (2013) 1.43
In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli. Antimicrob Agents Chemother (2010) 1.40
Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis. Clin Infect Dis (2006) 1.38
Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities. Diagn Microbiol Infect Dis (2010) 1.35
Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology. Clin Infect Dis (2004) 1.30
Identification of carbapenem-resistant klebsiella pneumoniae harboring KPC enzymes in New Jersey. Microb Drug Resist (2007) 1.27
Are three sputum acid-fast bacillus smears necessary for discontinuing tuberculosis isolation? J Clin Microbiol (2002) 1.22
Quinolone-resistant Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV. Antimicrob Agents Chemother (2004) 1.20
Cutaneous metastasis to the chest wall from prostate cancer. Int J Dermatol (2006) 1.20
Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries. J Clin Microbiol (2006) 1.09
Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia. J Infect Dis (2013) 1.09
Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance. Antimicrob Agents Chemother (2005) 1.09
Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinity. J Clin Microbiol (2010) 1.09
Challenges to conducting a clinical trial of combination therapy of colistin and rifampicin for extensively drug-resistant Acinetobacter baumannii. Clin Infect Dis (2013) 1.08
Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin. Antimicrob Agents Chemother (2004) 1.04
A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia. BMC Infect Dis (2013) 1.03
Identification of CTX-M β-lactamases among Escherichia coli from the community in New York City. Diagn Microbiol Infect Dis (2012) 1.01
Virulence and plasmid transferability of KPC Klebsiella pneumoniae at the Veterans Affairs Healthcare System of New Jersey. Microb Drug Resist (2012) 1.00
Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites. Clin Infect Dis (2002) 0.99
Subacute endocarditis caused by Gemella haemolysans and a review of the literature. Scand J Infect Dis (2004) 0.98
The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials. Int J Infect Dis (2010) 0.98
Subcutaneous fungal infections. Dermatol Ther (2004) 0.98
Biological and clinical basis for molecular studies of interferons. Methods Mol Med (2005) 0.95
Corynebacterium bovis line related septicemia: a case report and review of the literature. Scand J Infect Dis (2008) 0.95
Polymyxin-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother (2010) 0.94
Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns. Pharmacotherapy (2012) 0.90
Increased mortality associated with a clonal outbreak of ceftazidime-resistant Klebsiella pneumoniae: a case-control study. Infect Control Hosp Epidemiol (2005) 0.90
Endocarditis due to Corynebacterium amycolatum. J Med Microbiol (2008) 0.90
Selected sexually transmitted diseases and their relationship to HIV. Clin Dermatol (2004) 0.90
Plasmid transferability of KPC into a virulent K2 serotype Klebsiella pneumoniae. BMC Infect Dis (2014) 0.89
The prevalence and virulence characteristics of enteroaggregative Escherichia coli at an urgent-care clinic in the USA: a case-control study. J Med Microbiol (2009) 0.89
Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin. Case Rep Med (2012) 0.88
K2 serotype Klebsiella pneumoniae causing a liver abscess associated with infective endocarditis. J Clin Microbiol (2009) 0.88
Polymyxin Combination Therapy and the Use of Serum Bactericidal Titers in the Management of KPC-Producing Klebsiella pneumoniae Infections: A Report of 3 Cases. Case Rep Med (2011) 0.88
Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responses. Antiviral Res (2004) 0.87
Community-associated Escherichia coli harboring CTX-M β-lactamases from urine cultures from pediatric patients. Antimicrob Agents Chemother (2012) 0.86
Tricuspid valve endocarditis caused by Haemophilus parainfluenzae: a case report and review of the literature. Diagn Microbiol Infect Dis (2009) 0.86
Impact of contact and droplet precautions on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus infection. Infect Control Hosp Epidemiol (2007) 0.85
An unusual presentation of two simultaneous primary melanomas. Int J Dermatol (2006) 0.83
Impact of adding maraviroc to antiretroviral regimens in patients with full viral suppression but impaired CD4 recovery. AIDS (2009) 0.83
Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs. J Antimicrob Chemother (2013) 0.83
Rickettsial infections around the world, part 1: pathophysiology and the spotted fever group. J Cutan Med Surg (2005) 0.82
Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations. J Am Acad Dermatol (2004) 0.82
Comparison of serotonin toxicity with concomitant use of either linezolid or comparators and serotonergic agents: an analysis of Phase III and IV randomized clinical trial data. J Antimicrob Chemother (2011) 0.81
Antibody response of healthy adults to recombinant thrombospondin-related adhesive protein of cryptosporidium 1 after experimental exposure to cryptosporidium oocysts. Clin Diagn Lab Immunol (2004) 0.81
Unrelated strain methicillin-resistant Staphylococcus aureus colonization of health care workers in a neonatal intensive care unit: findings of an outbreak investigation. Am J Infect Control (2013) 0.81
Psoas abscess due to Mycobacterium xenopi infection. Am J Med (2003) 0.80
Therapy of systemic fungal infections. Dermatol Ther (2004) 0.80
Comparison of a hospital-wide antibiogram with that of an associated long-term care facility. J Am Geriatr Soc (2012) 0.79
The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea. Ther Clin Risk Manag (2009) 0.79
Linezolid and vancomycin in treatment of lower-extremity complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus in patients with and without vascular disease. Surg Infect (Larchmt) (2012) 0.78
Identification of extended-spectrum-β-lactamase-positive Klebsiella pneumoniae urinary tract isolates harboring KPC and CTX-M β-lactamases in nonhospitalized patients. Antimicrob Agents Chemother (2013) 0.77
Prosthetic Joint Infection due to Mycobacterium bovis after Intravesical Instillation of Bacillus Calmette-Guerin (BCG). Int J Microbiol (2009) 0.77
Advances in antiviral therapy. Dermatol Clin (2005) 0.77
Clinical outcomes by methicillin-resistant Staphylococcus aureus staphylococcal cassette chromosome mec type: isolates recovered from a phase IV clinical trial of linezolid and vancomycin for complicated skin and skin structure infections. Antimicrob Agents Chemother (2010) 0.77
The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycin. J Antimicrob Chemother (2010) 0.76
Concomitant administration of BILR 355/r with emtricitabine/tenofovir disoproxil fumarate increases exposure to emtricitabine and tenofovir: a randomized, open-label, prospective study. Basic Clin Pharmacol Toxicol (2010) 0.76
Coadministration with lopinavir and ritonavir decreases exposure to BILR 355, a nonnucleoside reverse transcriptase inhibitor, in healthy volunteers. J Clin Pharmacol (2010) 0.76
Contagious acute gastrointestinal infections. N Engl J Med (2005) 0.76
Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Ther (2013) 0.76
Postherpetic poliosis. Arch Dermatol (2006) 0.76
Basal cell and squamous cell carcinoma in persons younger than 40 years. JAMA (2006) 0.75
Levofloxacin-resistant-Streptococcus mitis endophthalmitis: a unique presentation of bacterial endocarditis. J Med Microbiol (2009) 0.75